Skip to main content
. 2020 Dec 21;64(1):26–41. doi: 10.1021/acs.jmedchem.0c00931

Figure 5.

Figure 5

Design of dual GSK-3β/AChE inhibitors 5 and 6. Tacrine has been extensively used to develop MTDLs by linking a structure responsible for inducing a second biological effect. In the cases reported in the figure, GSK-3β inhibitor 4 has been coupled to tacrine to obtain compound 5 by taking advantage of the amide in 4 localized in solvent-exposed portion of the molecule. In the second example, to obtain compound 6, the structure of valmerin has been used as GSK-3β binding-fragment.